<DOC>
	<DOCNO>NCT00837486</DOCNO>
	<brief_summary>Medtronic , Inc. sponsor investigational study Reclaim™ Deep Brain Stimulation ( DBS ) System people treatment-resistant depression . Depression mood disorder serious medical condition affect million Americans . Depressive symptom may include loss interest thing typically enjoy ; decrease energy level ; difficulty concentrate make decision ; restlessness ; feeling pessimism , hopelessness , worthlessness . Treatment-resistant depression chronic severe form depression characterize failure respond traditional form treatment , antidepressant medication electroconvulsive therapy . Treatment-resistant depression significantly impact quality life , productivity , major contributor disability world-wide . This randomized , double-blind , sham stimulation-controlled , multi-center , prospective , parallel design study use deep brain stimulation technology test whether active bilateral stimulation safely effectively improve depressive symptom patient treatment-resistant depression compare sham stimulation . Participants meet criterion study implant Reclaim DBS System . Participants active group , receive active stimulation , compare control group , receive sham stimulation , 16-week blinded-treatment phase . All participant monitor change depressive symptom . After blinded-treatment phase , participant receive active stimulation . Candidates trial adult major depressive disorder respond several treatment depression . Participants study continue receive current antidepressant medication participate trial .</brief_summary>
	<brief_title>Reclaim Deep Brain Stimulation Clinical Study Treatment-Resistant Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>Consent participate screening study procedure sign date Informed Consent Form Are diagnosed major depressive disorder ( MDD ) Have try least 4 different treatment , example antidepressant medication , combination antidepressant medication , and/or electroconvulsive therapy ( ECT ) Screening MADRS score ≥ 28 Have current major depressive episode persist least 2 year Females , childbearing potential , must use acceptable method birth control Females : Currently pregnant Currently enrol plan enroll concurrent drug and/or device study may confound result study Have neurological condition may jeopardize safety conduct study Have medical condition unsuitable undergoing DBS surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Treatment Resistant Depression</keyword>
	<keyword>Treatment Refractory Depression</keyword>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Depression</keyword>
</DOC>